Iron Triangle Partners as of March 31, 2021
Portfolio Holdings for Iron Triangle Partners
Iron Triangle Partners holds 27 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Encompass Health Corp (EHC) | 8.1 | $64M | 775k | 81.90 | |
| UnitedHealth (UNH) | 7.6 | $60M | 160k | 372.07 | |
| Zimmer Holdings (ZBH) | 7.5 | $59M | 370k | 160.08 | |
| Molina Healthcare (MOH) | 5.9 | $47M | 200k | 233.76 | |
| Horizon Therapeutics Pub L SHS | 5.9 | $46M | 500k | 92.04 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 5.5 | $43M | 170k | 255.03 | |
| Charles River Laboratories (CRL) | 5.2 | $41M | 140k | 289.83 | |
| Align Technology (ALGN) | 4.8 | $38M | 70k | 541.53 | |
| Envista Hldgs Corp (NVST) | 4.7 | $37M | 910k | 40.80 | |
| Haemonetics Corporation (HAE) | 4.7 | $37M | 330k | 111.01 | |
| Abbvie (ABBV) | 4.1 | $33M | 300k | 108.22 | |
| Surgery Partners (SGRY) | 4.1 | $32M | 725k | 44.26 | |
| Pacific Biosciences of California (PACB) | 4.0 | $31M | 936k | 33.31 | |
| Pulmonx Corp (LUNG) | 3.5 | $27M | 600k | 45.74 | |
| CONMED Corporation (CNMD) | 3.3 | $26M | 200k | 130.59 | |
| Nevro (NVRO) | 3.2 | $25M | 180k | 139.50 | |
| Iqvia Holdings (IQV) | 2.5 | $19M | 100k | 193.14 | |
| Oak Street Health | 2.4 | $19M | 350k | 54.27 | |
| IDEXX Laboratories (IDXX) | 2.2 | $17M | 35k | 489.31 | |
| Guardant Health (GH) | 1.9 | $15M | 100k | 152.65 | |
| Natera (NTRA) | 1.9 | $15M | 150k | 101.54 | |
| EXACT Sciences Corporation (EXAS) | 1.7 | $13M | 100k | 131.78 | |
| Dermtech Ord ord (DMTK) | 1.6 | $13M | 250k | 50.79 | |
| Orion Acquisition Corp Unit 02/19/2026 | 1.4 | $11M | 1.1M | 9.99 | |
| Vericel (VCEL) | 1.1 | $8.9M | 160k | 55.55 | |
| Outset Med (OM) | 0.7 | $5.4M | 100k | 54.39 | |
| Royalty Pharma Shs Class A (RPRX) | 0.6 | $4.4M | 100k | 43.62 |
